Among uremic toxins in the middle molecular mass range, 3C-nuclear magnetic resonance, ultraviolet spectrometry, and chromatographic analyses allow identification of the main component of the so-called "2-5-3 fraction" as ascorbic acid 2-sulfate, a conjugated metabolite of ascorbic acid. We previously (Clin Nephrol 1986;25:21 2-8) showed an inhibitory effect of the 2-5-3 fraction on microtubule formation. Therefore, we tested the action of ascorbic acid 2-sulfate and its synthetized enantiomers on tubulin polymerization. Because these molecules did not exert any inhibitory effect, we hypothesize that the 2-5-3 fraction is a mixture of compounds in which only a very low quantity of the inhibitory factor is present.
chromatography, ion-pair
Since postulation of the "middle molecules" hypothesis by Babb et al. (1) , numerous attempts have been made to separate and identify substances in the molecular mass range of 300-2000 Da that accumulate in uremic fluids and exert toxic effects (2) . The chemical nature of these substances appears to be highly diverse, being reported as (e.g.) peptidic substances (3) (4) (5) (6) (7) , carbohydrates (8, 9) , or a double conjugate of glucuronidate-O-hydroxyhippuric acid (10) . Later we identified the same double conjugate molecule (11) and three others that were also glucurono-conjugates of phenolic acids (12, 13) .
Among the middle molecular mass compounds, we previously reported that a particular chromatographic fraction, the so-called "2-5-3 fraction," inhibits microtubule formation (14, 15) and speculated that these results might be correlated with the occurrence of uremic neuropathy. We report here the identification of one of these components.
Materials and Methods

Isolation of the 2-5-3 Fraction
The uremic toxins were isolated by using a semi-preparative method as previously described (11, 16 Table 2 , the carbonatoms are numberedclockwise, with 1 being to the right of the oxygen atom in the ring and 6 being the left-most carbon mg, fraction 2-5 is divided into 10 components (2-5-1 through 2-5-10) by ion-pair high-performance liquid chromatography (HPLC) involving tetrabutylanimonium phosphate as a counter-ion.
Finally, after removal of the counter ion, the 2-5-3 fraction thus isolated (as its sodium salt) is stored lyophilized.
Identification of the 2-5-3 Fraction
1H and 13C nuclear magnetic resonance spectrometry: were classically performed by spectrum integration, homonuclear double irradiation, and comparison with standard compounds recorded under the same conditions. For comparison we used L-ascorbic acid, sodium salt (AA); L-ascorbic acid 2-sulfate, dipotassium salt (AAS); and their synthetized isomers (see Figure 1 and below).
The 13C NMR spectra were recorded at 50.32 MHz with a Bruker AM200 for the AA and AAS compounds and at 100.57 MHz with a Bruker AM 400 (Societe Broker, Wissembourg, France) spectrometer for the 2-5-3 fraction. For the standard compounds, typical experimental conditions were as follows: sweep width 11 900 Hz, pulse width 8 s, acquisition time 0.69 s, number of scans 300. For the 2-5-3 fraction, the conditions were as follows: sweep width 20 000 Hz, pulse width 2.5 s, acquisition time 0.82 s, number of scans 173 000. 6Nonstandard abbreviations: NMR, nuclear magnetic resonance; AA, ascorbic acid; AAS, ascorbic acid 2-sulfate; and DEAE, diethylaminoethyl.
Ascorbic acid (Na salt) The 2-5-3 fraction (=0.3 g/L) and the AAS compound placed in a 10-mm (o.d.) tube were studied at 20.0 (±0. 
Ultraviolet spectrometry:
Comparative spectra were obtained for aqueous and hydrochloric acid (0.1 mol/L) solutions of AA (50 j.moL'L), AAS (60 pmol/L), and the 2-5-3 fraction (20 mg/L). Ultraviolet spectra were obtained with a Beckman DU 70 spectrophotometer (Beckman Instruments, Brea, CA), and the absorption maxima (A max) were recorded.
Chromatographic analyses: First, we used Sephadex DEAE A25 chromatography on AA and AAS solutions in Ti-isO HC1 buffer (10 mmol/L, pH 8.6) at a flow rate of 26 mL -h1. The chromatographic conditions were as described previously (16) . We compared the retention times of AA, AAS, and the 2-5 fraction.
Next, we performed an ion-pair HPLC analysis as previously reported (11, 16) , using aqueous solutions of AAS (1 mmol/L), the 2-5 fraction (4 g/L), and a solution of the 2-5 fraction loaded with AAS (10 mmol/L).
We compared the retention times of the compounds and, in the loading experiment, measured the variations in peak intensity. 
Synthesis of Ascorbic
D-
araboascorbic (R-R) acids, respectively, by heating with excess NaOH in aqueous methanol according to Brenner's method (17) .
The sulfation of each diastereoisomeric pair with sulfur trioxide-trimethylamine complex was carried out in basic medium, as described by Tolbert et al. (18) . The synthetized compounds were purified as sodium salts by using our chromatographic procedure (see above); the total concentration of each mixture of isomers was measured by ultraviolet absorption at 254 nm, for which the molar absorptivity was 17 000 L -moF' -cm' (18) .
The components of the mixture of epimers were identified and quantified by using 'H-NMR spectra for L-arabo/ L-xyloascorbic acid 2-sulfate
50/50 (L-arabo AAS/L-xylo AAS) and D-arabo/D-xyloascorbic acid 2-sulfate 70/30 (Darabo AAS/D-xylo AAS).
Microtubule Formation
Preparation of tubulin: Microtubular protein, i.e., tubu lin 6S with microtubule-associated proteins, was obtaine from fresh pig brains by the method of Shelanski et al. (19) tubulin 6S was purified from microtubular protein by usini a phosphocellulose column, according to Weingarten et al (20) . Tubulin purity was verified by polyacrylamide ge electrophoresis (21) . We determined tubulin concentratiot spectrophotometrically, using the absorptivity value of 1. L -cm'g1 (22) . Polymerization study: Microtubules were obtaine through polymerization of tubulin 6S, and their formatiot was classically monitored by recording the increase it turbidity, as previously described (14) . In the presen study, we monitored the absorbance at 340 nm. To start thi polymerization, we heated the samples from 4 #{176}C to 37 #{176}C The buffer used contained, 
Results and Discussion
The identification
of the 2-5-3 fraction as AAS is also well supported by the comparative chromatographic analyses.
Indeed, ion-exchange chromatography on Sephadex DEAE A25 showed very similar retention times for the 2-5 fraction (398 rain), the AAS (405 mm), and the 2-5-3 fraction (399 mm), whereas the retention time for AA was only 20 mm. Ion-pair HPLC showed identical retention times for AAS (12.30 mm) and the 2-5-3 fraction (1232 mm).
In addition, the HPLC analysis of the 2-5 fraction loaded with AAS showed an increase in the 2-5-3 peak intensity as compared with that peak in analysis of the 2-5 fraction alone, whereas the intensity of the other peaks remained unchanged ( Figure 2 ). (15) . NS, notsignificant.
We concluded from our results that the 2-5-3 fraction is an ascorbic acid metabolite: ascorbic acid 2-sulfate.
Tubulin Activity
We previously demonstrated that the 2-5-3 fraction inhibits microtubule formation in vitro (14, 15) , and we correlated this finding with the occurrence of uremic neuropathy in some patients (14) . Therefore, we wanted to verify whether AAS exhibits in vitro activity on tubulin polymerization. Table 3 (where we also include our previous results for the 2-5-3 fraction) show that AAS is inactive regarding tubulin polymerization.
Results in
However, we emphasize that this lack of effect was observed with a dose (0.25 g/L) about 10-fold higher than the concentration of 2-5-3 fraction in plasma from uremic patients. The presence of two asymmetric carbons in the AAS molecule led us to suspect an isomeric specificity of the activity. We therefore synthetized the four corresponding enantiomers and tested their activities on tubulin polymerization.
However, these compounds also are without any activity (Table 3) . 
